ARUP's Laboratory Test Directory

Beta-hCG, CSF Quantitative (Tumor Marker) : 0020730

Mnemonic: BHCG CSF

Methodology: Chemiluminescent Immunoassay
Performed: Sun-Sat
Reported: Within 24 hours
Specimen Required: Collect:  CSF.

Transport:  0.5 mL CSF at 2-8°C. (Min: 0.2 mL) Submit specimen in an ARUP Standard Transport Tube.

Stability:  Ambient: 8 hours; Refrigerated: 1 week; Frozen: 2 months
Reference Interval:
18 years and older: 0-3 IU/L
Interpretive Data: The Siemens Immulite® 2000 BHCG chemiluminescent immunoassay is used. Results obtained with different assay methods or kits cannot be used interchangeably. Human chorionic gonadotrophin (hCG) is a valuable aid in the management of patients with trophoblastic tumors, nonseminomatous testicular tumors, and seminomas when used in conjunction with information available from the clinical evaluation and other diagnostic procedures. Increased hCG concentrations have also been observed in melanoma, carcinomas of the breast, gastrointestinal tract, lung, and ovaries, and in benign conditions including cirrhosis, duodenal ulcer, and inflammatory bowel disease. The result cannot be interpreted as absolute evidence of the presence or absence of malignant disease. The result is not interpretable as a tumor marker in pregnant females. This assay is FDA cleared for use in the detection of pregnancy, but is not labeled for use as a tumor marker, or with CSF specimens.
CPT Code(s): 84702
 
 

 

 

 
All ARUP Sites:        www.aruplab.com     ·     www.arupconsult.com     ·     www.arup.utah.edu     ·     www.childx.org     ·     www.utahblood.org